We talk to Tamika Jean-Baptiste, Vice President and Chief Diversity Officer, Amgen, who discusses her lifelong passion for diversity both in the workplace and in life. Tamika explores the importance of aligning your purpose and your passion, how best to draw young people into pharma, leveraging employee resource groups, and the significance of filling your own cup before reaching for others.

We speak to Chumi Khurana, Global Head, Prostate Cancer Disease Area Stronghold, Janssen Oncology about her pathway into men’s health, the challenges and potential solutions in the realm of prostate disease, and her advice for family and caregivers on how best to support a loved one who is dealing with a prostate cancer diagnosis.

We talk to Dr Richard Kaszynski, Chief Medical Officer, AiPharma, who discusses the emerging role of antivirals in healthcare. He explores his work on the GUARDIAN program, the benefits of drug repurposing, the importance of keeping patients out of hospitals and his highlights from the past year.

This week, Tanja Dowe, CEO, Debiopharm Innovation Fund, discusses her passion for digital health tools. Drawing on her experience of investing in health technologies, she explores what it takes to be a successful entrepreneur, how these tools could improve life expectancies in cancer, and her highlights from a year of digital transformation for the pharmaceutical industry.

This week, we take a look back at the standout moments in the pharmaceutical industry from October, covering the latest in COVID-19 developments, the most notable mergers and acquisitions, marketing highlights, and the latest in research and development.

We talk to Dr Emma Roffe, Oncology Country Head, Takeda UK, and Eric Low, Founder, Myeloma UK, about the challenge of combination treatments. The two discuss a pair of whitepapers recently produced by Takeda, which uncover why challenges exist, why for so long it has been classified as ‘too hard to solve’, as well as potential solutions that could revolutionise this area of healthcare. Disclaimer: This episode is editorially owned by EMG GOLD.

We talk to Massimiliano Siciliano, Digital Solution Director Europe, Novartis, about the potential of digital solutions for the pharmaceutical industry’s stakeholders and commercial teams, the technology he is most excited about within pharma’s digital revolution, and his three key principles for building high performing teams.

We talk to Clare Hague, Senior Director, Haematology Market Access, Europe, the Middle East, and Africa, Janssen. She shares her perspective on the industry’s drug pricing challenges and opportunities, details alternative pricing systems that could improve access in low-to-middle-income countries, and explores the shifting market access landscape within oncology.

This week, we look back at the highlights in pharma throughout September, covering the latest in COVID-19 developments, the most notable mergers and acquisitions, marketing standouts, and the latest in research and development news.

We talk to Matt Atkinson, Global Projects Director, Reuters Events Pharma, and Megan Reutin, Global Head of Omnichannel Analytics, Grünenthal Group, about the upcoming Reuters Pharma 2021 Event. We get a sneak peek into the event's line-up, consider the future of virtual events, and explore the rapid digital transformation that has taken place over the past year.